Sfoglia per Autore
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo
1996 P. Bagnarelli, A. Valenza, S. Menzo, R. Sampaolesi, P.E. Varaldo, L. Butini, M. Montroni, C.F. Perno, S. Aquaro, D. Mathez, J. Leibowitch, C. Balotta, M. Clementi
Impact of mutations conferring reduced susceptibility to lamivudine (3TC) on the response to antiretroviral therapy.
2001 C.F. Perno, A. Cozzi Lepri, C. Balotta, F. Forbici, M. Violin, A. Bertoli, G. Facchi, P. Pezzotti, G. Angarano, C. Arici, P. Narciso, A. Orani, E. Raise, A. Scalzini, A. Poggio, G. Ippolito, M. Moroni, A. d’Arminio Monforte and the ICONA Study Group.
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy
2001 CF Perno, A Cozzi-Lepri, C Balotta, F Forbici, M Violin, A Bertoli, G Facchi, P Pezzotti, G Cadeo, G Tositti, S Pasquinucci, S Pauluzzi, A Scalzini, B Salassa, A Vincenti, AN Phillips, F Dianzani, A Appice, G Angarano, L Monno, G Ippolito, M Moroni, A d' Arminio Monforte
Increasing prevalence of non-clade B HIV-1 strains in heterosexuals, as monitored by the analysis of the RT and protease sequences.
2001 C. Balotta, G. Facchi, M. Violin, S. Van Dooren, A. Cozzi-Lepri, F. Forbici, A. Bertoli, D. Senese, P. Caramello, G. Carnevale, G. Rizzardini, L. Cremonini, L. Monno, G. Rezza, C.F. Perno, G. Ippolito, A. d’Arminio-Monforte, A.M. Vandamme, M. Moroni
Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy
2001 C.F. Perno, A. Cozzi-Lepri, C. Balotta, F. Forbici, M. Violin, A. Bertoli, G. Facchi, P. Pezzotti, G. Angarano, C. Arici, P. Narciso, A. Orani, E. Raise, A. Scalzini, A. Poggio, G. Ippolito, M. Moroni, A. D'Arminio Monforte, M. Montroni, G. Scalise, A. Costantini, M.S. Del Prete, U. Tirelli, G. Nasti, G. Pastore, L.M. Perulli, F. Suter, F. Chiodo, F.M. Gritti, V. Colangeli, C. Fiorini, L. Guerra, G. Carosi, G.P. Cadeo, F. Castelli, C. Minardi, D. Vangi, G. Rizzardini, G. Migliorino, P.E. Manconi, P. Piano, T. Ferraro, L. Cosco, E. Pizzigallo, F. Ricci, G.M. Vigevani, L. Pusterla, G. Carnevale, A. Pan, P. Viganò, M. Mena, F. Ghinelli, L. Sighinolfi, F. Leoncini, F. Mazzotta, S. Ambu, S. Lo Caputo, G. Angarano, B. Grisorio, S. Ferrara, P. Grima, P. Tundo, G. Pagano, N. Piersantelli, A. Alessandrini, R. Piscopo, M. Toti, M. Chigiotti, F. Soscia, L. Tacconi, A. Orani, G. Castaldo, A. Scasso, A. Vincenti, F. Scalzini, F. Alessi, M. Moroni
Secondary mutations in the protease region are predictors of virologival failure in antiretroviral-naive patients treated with protease inhibitors-containing HAART regimens.
2001 C.F. Perno, A. d’Arminio Monforte, C. Balotta, A. Cozzi Lepri, F. Forbici, M. Violin, A. Bertoli, G. Facchi, P. Pezzotti, G.P. Cadeo, G. Tositti, S. Pasquinucci, S. Pauluzzi, A. Scalzini, B. Salassa, A. Vincenti, A.N. Phillips, F. Dianzani, A. Appice, G. Angarano, L. Monno, G. Ippolito, M.M.F.T.I.C.O.N.A. Study Group
Virologic correlates of adherence to antiretroviral medications and therapeutic failure.
2002 C.F. Perno, F. Ceccherini-Silberstein, A. De Luca, A. Cozzi-Lepri, C. Gori, A. Cingolani, M.C. Bellocchi, M.P. Trotta, P. Piano, F. Forbici, A. Scasso, V. Vullo, A. d’Arminio Monforte, A. Antinori, for the AdICoNA Study Group.
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals
2002 M. Violin, F. Forbici, A. Cozzi-Lepri, R. Velleca, A. Bertoli, C. Riva, S. Giannella, P.E. Manconi, A. Lazzarin, S. Pasquinucci, L. Tacconi, G. Carnevale, F. Mazzotta, L. Bonazzi, M. Montroni, A. Chiarianni, M. Capobianchi, G. Ippolito, M. Moroni, C.F. Perno, A. D'Arminio Monforte, I.C.O.N.A
Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation
2002 CF Perno, A Cozzi-Lepri, C Balotta, A Bertoli, M Violin, L Monno, T Zauli, M Montroni, G Ippolito, A d'Arminio-Monforte
Low prevalence of primary mutations associated to drug resitance in antiretroviral-naive patients at initiation of HAART.
2002 C.F. Perno, A. Cozzi-Lepri, C. Balotta, F. Forbici, M. Violin, A. Bertoli, G. Facchi, P. Pezzotti, L. Monno, P.E. Manconi, F. Mazzotta, F. Del Fanti, L. Tacconi, M.R. Capobianchi, L. Bonazzi, T. Zauli, M. Montroni, M. Moroni, G. Ippolito, A. d’Arminio Monforte, for the I.CO.N.A. Study Group.
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy
2004 M. Violin, A. Cozzi Lepri, R. Velleca, A. Vincenti, S. D'Elia, F. Chiodo, F. Ghinelli, A. Bertoli, A. d'Arminio Monforte, C.F. Perno, M. Moroni, C. Balotta
Minor Mutations in HIV-Protease at Baseline and Appearance of Primary Mutation 90M in Patients Failing Their First Protease-Inhibitor Antiretroviral Regimens
2004 C.F. Perno, A. Cozzi Lepri, F. Forbici, A. Bertoli, M. Violin, M.S. Mura, G.P. Cadeo, A. Orani, A. Chirianni, C. De Stefano, C. Balotta, A. d’Arminio Monforte, I.CO.N.A Study Group
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure
2004 F. Ceccherini-Silberstein, F. Erba, F. Gago, A. Bertoli, F. Forbici, M.C. Bellocchi, C. Gori, R. D'Arrigo, L. Marcon, C. Balotta, A. Antinori, A. d'Arminio Monforte, C.F. Perno
The prognostic value to predict virological outcomes of 14 distinct systems used to interpret the results of genotypic HIV-1 drug resistance testing in untreated patients starting their first HAART
2004 A. De Luca, A. Cozzi Lepri, C.F. Perno, C. Balotta, S. Di Giambenedetto, A. Poggio, G. Pagano, G. Tositti, R. Piscopo, A. Del Forno, F. Chiodo, G. Magnani, A. D’Arminio Monforte, I.C.O.N.A. drug resistance study group, T.I.C.O.N.A. study group
Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems
2004 A. De Luca, A. Cozzi Lepri, C.F. Perno, C. Balotta, S. Di Giambenedetto, A. Poggio, G. Pagano, G. Tositti, R. Piscopo, A. Del Forno, F. Chiodo, G. Magnani, A. d'Arminio Monforte, I. drug resistance study group, I. study group
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001
2004 M. Violin, R. Velleca, A. Cozzi Lepri, C. Riva, P.A. Grossi, G. Carnevale, G. Rizzardini, E. Petrelli, C.F. Perno, A. d'Arminio Monforte, C. Balotta, I. Study Group
Correlation between M36I in HIV protease and selection/maintenance of L90M after treatment with protease inhibitors.
2005 C. Perno, A. Cozzi Lepri, F. Ceccherini Silberstein, A. D'ARMINIO MONFORTE, F. ICONA Study Group
Involvement of novel HIV-1 reverse transcriptase mutations in the highly ordered regulation of NRTI resistance
2005 F. Ceccherini Silberstein, V. Svicher, T. Sing, M. Santoro, N. Beerenwinkel, F. Gago, A. Bertoli, F. Forbici, M.C. Bellocchi, P. Narciso, A. d'Arminio Monforte, A. Antinori, C.F. Perno
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors
2005 V. Svicher, F. Ceccherini Silberstein, C. Erba, M. Santoro, C. Gori, M.C. Bellocchi, S. Giannella, M.P. Trotta, A. d’Arminio Monforte, A. Antinori, C.F. Perno
Key questions in antiretroviral therapy : Italian Consensus Workshop (2005)
2006 G. Carosi, C. Torti, M. Andreoni, G. Angarano, A. Antinori, S. Bonora, M. Borderi, A. Castagna, F. Castelli, R. Cauda, F. Chiodo, A. d'Arminio-Monforte, A. De Luca, G. Di Perri, F. Dianzani, G. Filice, M. Galli, A. Lazzarin, F. Maggiolo, R. Maserati, F. Mazzotta, M. Moroni, C.F. Perno, V. Vullo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile